JonSkiJr74 retweeted
👇🏽SHARE this OpEd by @Elijahjstacy. Both Elijah and his brother are battling #Duchenne. They need the FDA to arm them in that fight.
On a bipartisan basis, Congress has repeatedly called out the @FDA for not honoring Congessional intent in 21st Century Cures.
@FDADrugs and @FDA_KyleD Congess and @POTUS have spoken. Now the FDA now has its 1st chance to show whether it will honor its own proposed Rare Disease Framework by approving @Capricor's #deramiocel.
#RareDiseases #PDUFA #patientadvocacy #healthcare #MedTwitter #MedX #Neurology #neuromuscular #MuscularDystrophy
@GOPHELP @HELPCmteDems
@EnergyCommerce @HouseCommerce
@AnnieAndrewsMD @AbdulElSayed
@DrAmishShah @DrPanMD
@HamawyForNJ @RepKimSchrier
@RepHerbConaway @herbconaway
@RepDexterOR @DoctorMaxine
@KellyMorrisonMN @Morrison4MN
@RepRaulRuizMD @Bilirakis @DorisMatsui @RepGuthrie @RepAndyHarrisMD @RepJohnJoyce @RepMGriffith
@DrRandPaul @SenJohnBarrasso @SenSanders @lisamurkowski @SenatorWicker @SenGillibrand
Check out my latest piece in @theblaze on the FDA’s upcoming November 22 decision on deramiocel. The FDA has a chance to show rare disease patients that its promises were more than just talk. theblaze.com/columns/opinion…
JonSkiJr74 retweeted
.@POTUS give @houmanhemmati a call to be the next FDA commissioner. Incredibly qualified, scientifically rigorous, and a heart for patients.
I am confident that he can restore the American people’s faith in the agency, and win the support of both political persuasions.
JonSkiJr74 retweeted
$CAPR I’ve raised my FDA approval odds from 60% to 70% following today’s earnings call.
No additional FDA requests with 12 days until PDUFA, HOPE-3 met its primary upper-limb endpoint (p=0.029), and the narrower indication avoids relying on cardiac efficacy. Supportive extension data and no further inspections anticipated also strengthen the case.
Still, July’s negative AdCom vote and the outstanding Form 483 observation remain risks. FDA silence is not a guarantee.
Still a binary event, but I’m more optimistic. Do your own diligence.
JonSkiJr74 retweeted
$CAPR This is no longer about another committee vote. The decision is now in Karin Mikhail’s hands. With McDonald’s letter carrying 28 signatures and thousands of children and families waiting, there’s a lot riding on this decision.
The FDA’s response could also have broader implications for future rare disease biotech investments.
JonSkiJr74 retweeted
Check out my latest piece in @theblaze on the FDA’s upcoming November 22 decision on deramiocel. The FDA has a chance to show rare disease patients that its promises were more than just talk. theblaze.com/columns/opinion…
JonSkiJr74 retweeted
💵A missing deposit. 💳A lost debit card. 🏠A mortgage decision. Every member needs help, but each conversation needs a different kind of support.
American Heritage Credit Union (hubs.li/Q04FxCmm0) works with SoundHound AI to make that possible.
Its voice and chat AI agent, Gigi, transfers money, replaces debit cards, quotes loan payoff amounts, and more. That helps representatives focus on the situations that need personal guidance.
In less than a year, Gigi handled nearly 600,000 member interactions, resolving 88% of fraud and dispute chats without a representative, and achieving 100% completion on dispute inquiries, loan applications, and contact requests.
Full story in the replies.
JonSkiJr74 retweeted
$CAPR In the US alone there are 10,000 young men in wheelchairs who can benefit from Deramiocel.
The peer reviewed Lancet article stated both skeletal and cardiac muscle benefit (pp.2,9)
The Robustness analysis said the benefits are not "fragile"...they are ROBUST !
The American Heart Association Award is for the cardiac benefit !
All the DMD families want is for their boys to have better quality and longer lives. That is what we all want for our kids!
The FDA says they want to treat rare diseases fairly...now let them do what they say!
Bullish
JonSkiJr74 retweeted
Breaking: Ken Griffin’s Citadel just filed its Q3 2026 13F
They dumped 94% of their SpaceX $SPCX stake and 56% of their Amazon $AMZN stake
Here’s everything to know about their recent 13F
Top 10 positions:
• S&P 500 $SPY [Call]
• S&P 500 $SPY [Put]
• Nasdaq 100 $QQQ [Put]
• Nasdaq 100 $QQQ [Call]
• Meta $META [Call]
• Micron $MU [Put]
• Micron $MU [Call]
• Nvidia $NVDA [Call]
• AMD $AMD [Call]
• Apple $AAPL [Call]
New positions:
• ARK Innovation $ARKK
• Rocket Lab $RKLB
• Magnolia Oil & Gas $MGY
• Ryman Hospitality $RHP
• Jersey Mike’s
• FTAI Aviation $FTAI
Full exits:
• Electronic Arts $EA
• UMB Financial $UMBF
• Somnigroup $SGI
• AvalonBay solana:6d5zHW5B8RkGKd51Lpb9RqFQSqDudr9GJgZ1SgQZpump
• Chart Industries $GTLS
• Lincoln Electric $LECO
• Integer $ITGR
• Twist Bioscience $TWST
Biggest adds:
• Mastercard $MA: bought 161% more
• Microsoft $MSFT: bought 55% more
• Procter & Gamble $PG: bought 189% more
• Marvell $MRVL: bought 729% more
• Norfolk Southern $NSC: bought 146% more
Biggest trims:
• SpaceX $SPCX: sold 94%
• Amazon $AMZN: sold 56%
• Apple $AAPL: sold 37%
• AbbVie $ABBV: sold 81%
• Abbott $ABT: sold 80%
• Chevron $CVX: sold 76%
• AMD $AMD: sold 61%
Summary: 2,490 positions added and 2,219 fully closed out of 13,843 total, a $899,600,000,000 book































